Alkem Laboratories

Alkem Laboratories's reported carbon emissions

Alkem Laboratories, a pharmaceutical preparation manufacturer headquartered in India, is committed to reducing its greenhouse gas (GHG) emissions. For the fiscal year 2025, the company reported Scope 1 emissions of approximately 33,018,000 kg CO2e and Scope 2 emissions of approximately 76,079,000 kg CO2e. Looking at the previous year, fiscal year 2024, Alkem Laboratories's emissions were higher. Scope 1 emissions stood at approximately 19,249,000 kg CO2e, Scope 2 emissions at approximately 82,319,000 kg CO2e, and Scope 3 emissions at approximately 365,176,000 kg CO2e. The total combined Scope 1, 2, and 3 emissions for FY2024 were approximately 466,744,000 kg CO2e. Alkem Laboratories has set a significant climate commitment: to reduce its Scope 1 and 2 GHG emissions by 42% by fiscal year 2033, using fiscal year 2023 as the base year. This is a near-term, absolute reduction target covering all scopes. The company's reporting indicates that it is currently on track to meet these targets for both the two-year and five-year horizons. Emissions data for fiscal year 2023 included Scope 1 at approximately 19,249,000 kg CO2e, Scope 2 at approximately 82,319,000 kg CO2e, and Scope 3 at approximately 365,176,000 kg CO2e, with a total of approximately 466,744,000 kg CO2e. For fiscal year 2022, Alkem Laboratories reported Scope 1 emissions of approximately 15,773,000 kg CO2e and Scope 2 emissions of approximately 78,502,000 kg CO2e. In fiscal year 2021, Scope 1 emissions were approximately 20,621,000 kg CO2e and Scope 2 emissions were approximately 94,284,000 kg CO2e. Alkem Laboratories's climate initiatives are not cascaded from a parent organisation, with its sustainability performance sourced directly from Alkem Laboratories Limited. The company is actively working towards its emission reduction goals within the pharmaceutical preparation manufacturing sector.